Table 3. Relative risks for progression associated with combined marker status.
Variable | n | Relative risk | 95% Confidence interval | P |
---|---|---|---|---|
p53/p16 | ||||
Both normal | 35 | 1.00 | ||
One altered | 38 | 2.42 | 0.76–7.74 | 0.136 |
Both altered | 5 | 14.45 | 3.10–67.35 | 0.001 |
p53/pRb | ||||
Both normal | 32 | 1.00 | ||
One altered | 34 | 1.88 | 0.56–6.25 | 0.304 |
Both altered | 12 | 4.77 | 1.27–17.84 | 0.020 |
p16/pRb | ||||
Both normal | 46 | 1.00 | ||
One altered | 28 | 2.16 | 0.78–5.97 | 0.138 |
Both altered | 4 | 8.98 | 1.81–44.44 | 0.007 |
Cox proportional hazards regression.